Suplatast tosilate is under clinical development by Melius Pharma and currently in Phase II for Idiopathic Pulmonary Fibrosis.

Suplatast tosilate is an an immunoregulatory compound. It is formulated as hard gelatin capsules and dry syrup for oral route of administration. It is under development for idiopathic pulmonary ...

Antidepressants are prescription medications used to treat major depressive disorder (MDD, depression), a common mental health condition that can make you feel sad, worried, and hopeless and can ...

If you or a loved one is struggling with anxiety or depression, contact the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 800-662-4357 for information on ...

If OTC products don’t treat your lice or if infestations come back repeatedly, consider asking your doctor if you are treating the infestation properly or if prescription medications may help.

Recalled dog treats sold online and in stores in 19 U.S. states have been assigned the highest risk level by the U.S. Food and Drug Administration ... A dog is given a treat on a walk.

For every illegal drug, there is a combination of emojis that dealers and consumers use to evade detection on social media and messaging platforms. Snowflakes, snowfall, and snowmen symbolize cocaine.

Teva and Sanofi said last year they would collaborate on developing a treatment for inflammatory bowel disease (IBD), hoping it will become a blockbuster drug - or one that generates annual sales ...

Examples include certain seizure drugs, such as phenytoin (Dilantin, Phenytek). Before you start treatment with Trodelvy, tell your doctor and pharmacist which prescription, over-the-counter ...

opens new tab In addition to treatment of things like sleep apnea, the weight-loss drugs could lead to more joint replacements, said Sara Mallatt, director of healthcare research at market ...

Interstitial Cystitis Drugs Market Insights The global interstitial cystitis drugs market is estimated to valued at US$ 234.9 mn in 2023 & expected to exhibit CAGR of 6.9% during forecast period 2... ...